Disc Medicine (IRON) Operating Leases (2021 - 2026)

Disc Medicine (IRON) has reported Operating Leases for 6 consecutive years, with $1.2 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Operating Leases fell 22.28% year-over-year to $1.2 million; the TTM figure through Jun 2026 stood at $1.2 million (down 22.28% YoY), while the FY2025 annual figure was $1.3 million, down 19.06% from the prior year.
• Operating Leases fell to $1.2 million in Q2 2026 per IRON's latest filing, from $1.3 million in the prior quarter.
• Across five years, Operating Leases topped out at $1.8 million in Q2 2023 and bottomed at $945000.0 in Q1 2023.
• Historically, Operating Leases has averaged $1.4 million across 5 years, with a median of $1.4 million in 2025.
• Annual changes were most pronounced in 2024 — Operating Leases sank 39.16% — and 2025, when it soared 44.06%.
• Disc Medicine's Operating Leases stood at $1.0 million in 2022, then soared by 39.82% to $1.4 million in 2023, then gained by 7.8% to $1.5 million in 2024, then fell by 19.06% to $1.3 million in 2025, then dropped by 3.67% to $1.2 million in 2026.
• Business Quant data shows IRON's Operating Leases at $1.2 million in Q2 2026, $1.3 million in Q1 2026, and $1.3 million in Q4 2025.